Brief: Intervacc: Progress In Development Of New Vaccine Against Staphylococcus Aureus Infections

Intervacc AB

10/01/2018 07:30

Jan 10 (Reuters) - INTERVACC AB  IVACC.ST : 
    * SIGNIFICANT PROGRESS HAS BEEN MADE IN THE DEVELOPMENT OF A 
NEW 
VACCINE AGAINST STAPHYLOCOCCUS AUREUS INFECTIONS 
    * COSTS RELATED TO MASTITIS ARE ESTIMATED ANNUALLY ABOUT 
200 MSEK 
ONLY IN SWEDEN AND IN US ABOUT 4500 MSEK 
    * SAYS NEED FOR A VACCINE TO COMPLEMENT OTHER PREVENTIVE 
MEASURES 
IS VERY LARGE 
 
Source text for Eikon:  ID:nWkrMJ1SX  
Further company coverage:  IVACC.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))